205 related articles for article (PubMed ID: 12168095)
1. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumor cells from renal carcinoma patients: experiences of a two-center study.
Blümke K; Bilkenroth U; Schmidt U; Melchior A; Füssel S; Bartel F; Heynemann H; Fornara P; Taubert H; Wirth MP; Meye A
Oncol Rep; 2005 Oct; 14(4):895-9. PubMed ID: 16142348
[TBL] [Abstract][Full Text] [Related]
3. Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
Bluemke K; Bilkenroth U; Meye A; Fuessel S; Lautenschlaeger C; Goebel S; Melchior A; Heynemann H; Fornara P; Taubert H
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2190-4. PubMed ID: 19661076
[TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro.
Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
J Urol; 2000 Nov; 164(5):1834-7. PubMed ID: 11025779
[TBL] [Abstract][Full Text] [Related]
5. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro.
Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
J Urol; 2003 Feb; 169(2):701-5. PubMed ID: 12544346
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood.
Rosenberg R; Gertler R; Friederichs J; Fuehrer K; Dahm M; Phelps R; Thorban S; Nekarda H; Siewert JR
Cytometry; 2002 Dec; 49(4):150-8. PubMed ID: 12454978
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
8. Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.
Schmidt U; Bilkenroth U; Linné C; Fuessel S; Kraemer K; Froehner M; Wirth MP; Meye A
Int J Oncol; 2004 Jun; 24(6):1393-9. PubMed ID: 15138579
[TBL] [Abstract][Full Text] [Related]
9. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
10. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
11. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
[TBL] [Abstract][Full Text] [Related]
12. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.
Partridge M; Phillips E; Francis R; Li SR
J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599
[TBL] [Abstract][Full Text] [Related]
13. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
[TBL] [Abstract][Full Text] [Related]
14. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
[TBL] [Abstract][Full Text] [Related]
15. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
[TBL] [Abstract][Full Text] [Related]
16. [Separation of urologic tumors cells from Cell Saver blood using a membrane filter. A new method in autotransfusion?].
Wiesel M; Güdemann C; Staehler G; Bierhaus A; Martin E; Hoever KH
Urologe A; 1992 May; 31(3):182-5. PubMed ID: 1615592
[TBL] [Abstract][Full Text] [Related]
17. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
Wong SC; Chan CM; Ma BB; Hui EP; Ng SS; Lai PB; Cheung MT; Lo ES; Chan AK; Lam MY; Au TC; Chan AT
Clin Cancer Res; 2009 Feb; 15(3):1005-12. PubMed ID: 19188172
[TBL] [Abstract][Full Text] [Related]
19. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
